Target intelligence / Profile preview

Nonspecific blood components and vascular tissue

Molecular classification
Other
01

Overview

Nonspecific blood components and vascular tissue refers to the collective physical and chemical environment of the circulatory system, including plasma proteins, blood cells, and the endothelial lining of blood vessels (DrugBank Online, 2024). This category is typically used for drugs that exert their effects through non-specific physical or chemical mechanisms rather than binding to a specific molecular receptor (StatPearls, 2023). For example, plasma expanders like dextran increase oncotic pressure to treat hypovolemia, while osmotic diuretics like mannitol alter blood tonicity to reduce intracranial pressure (NIH, PubChem CID 6035). These interactions are crucial for managing conditions like shock, edema, and fluid imbalances (PubMed, PMC2596701). Because this "target" represents a physiological environment rather than a discrete molecule, it is primarily used for agents with non-specific or physical modes of action (DrugBank Online, 2024). This classification is essential for understanding the pharmacodynamics of substances that provide structural support, alter fluid dynamics, or serve as diagnostic contrast media within the vascular system.

Other names
Blood componentsVascular tissuePlasma and vessel wallsVascular compartment
02

Mechanism of action

Drugs acting on this target typically function through physical or chemical properties such as osmotic pressure modulation, volume expansion, or non-specific binding to plasma proteins and vessel walls.

03

Biological functions

Osmotic balanceHemostasisFluid transportVascular integrity
04

Disease associations

HypovolemiaEdemaHemorrhageThrombosisShock
05

Safety considerations

Fluid overloadElectrolyte imbalanceAnaphylactoid reactionsAcute kidney injuryCoagulopathy
06

Interacting drugs

Dextran

6 more in the full profile.

07

Biomarkers

Plasma osmolarityHematocritMean arterial pressureProthrombin time (PT)Activated partial thromboplastin time (aPTT)

Beyond the preview

Go deeper on Nonspecific blood components and vascular tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nonspecific blood components and vascular tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call